PT448 – Ibogaine, Noribogaine, and the Challenges of Federal Drug Policy

Reunion Neuroscience Inc. to Participate in October Investor Conferences

Clearmind Medicine to Present at the 8th Annual Dawson James Conference...

The Premiere of our New Short Film Vital Psychedelic Training: Creating...

Gratitude Revealed: Film Screening and Q&A with Director Louie Schwartzberg

Sunstone Therapies Announces Expansion of Innovative Dyad Study

PT447 – Exile & Ecstasy: The Intersection of Jewish Culture, Spirituality,...

Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and...

atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in...

Disposition of Common Shares of Small Pharma Inc.

Load more